Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Free Cash Flow (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Free Cash Flow for 15 consecutive years, with -$1.9 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow rose 0.61% to -$1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.9 million through Dec 2025, down 10.47% year-over-year, with the annual reading at -$5.9 million for FY2025, 10.47% down from the prior year.
  • Free Cash Flow for Q4 2025 was -$1.9 million at Creative Medical Technology Holdings, down from -$1.2 million in the prior quarter.
  • The five-year high for Free Cash Flow was -$222139.0 in Q2 2021, with the low at -$3.8 million in Q1 2023.
  • Average Free Cash Flow over 5 years is -$1.5 million, with a median of -$1.2 million recorded in 2023.
  • The sharpest move saw Free Cash Flow plummeted 2137.93% in 2021, then skyrocketed 76.65% in 2024.
  • Over 5 years, Free Cash Flow stood at -$1.2 million in 2021, then tumbled by 209.23% to -$3.6 million in 2022, then soared by 47.23% to -$1.9 million in 2023, then dropped by 2.88% to -$1.9 million in 2024, then grew by 0.61% to -$1.9 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$1.9 million, -$1.2 million, and -$1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.